Singapore markets closed

ADC Therapeutics SA (ADCT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.9700+0.2900 (+6.20%)
At close: 04:00PM EDT
5.0900 +0.12 (+2.41%)
Pre-market: 09:09AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
69,558
69,558
209,908
33,917
0
Cost of revenue
2,529
2,529
3,301
1,393
0
Gross profit
67,029
67,029
206,607
32,524
0
Operating expenses
Research development
127,127
127,127
186,457
158,002
142,032
Selling general and administrative
105,888
105,888
143,494
136,242
77,231
Total operating expenses
232,080
232,080
329,594
293,878
218,679
Operating income or loss
-165,051
-165,051
-122,987
-261,354
-218,679
Interest expense
46,325
46,325
36,731
18,340
4,926
Total other income/expenses net
5,417
5,417
10,333
28,123
-23,190
Income before tax
-195,419
-195,419
-146,817
-251,505
-245,963
Income tax expense
39,106
39,106
227
-21,479
327
Income from continuing operations
-240,053
-240,053
-157,128
-230,026
-246,290
Net income
-240,053
-240,053
-157,128
-230,026
-246,290
Net income available to common shareholders
-240,053
-240,053
-157,128
-230,026
-246,290
Basic EPS
-2.18
-
-2.01
-3.00
-3.77
Diluted EPS
-2.18
-
-2.01
-3.00
-3.77
Basic average shares
81,260
-
78,153
76,748
65,410
Diluted average shares
81,260
-
78,153
76,748
65,410